Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Offerings

Offerings Recent News

Venu Holding Stock Hits 52-Week Low - Here's Why
Venu Holding Stock Hits 52-Week Low - Here's Why
Venu Holding Corp. (NYSE: VENU) fell after announcing a $75 million public offering. Stock price down 49% in past year, RSI shows oversold.
Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why
Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why
Calidi Biotherapeutics shares plunged after hours following a public offering announcement, trading near their 52-week low.
Why Did CDT Environmental Tech (CDTG) Stock Pop 42% After Hours
Why Did CDT Environmental Tech (CDTG) Stock Pop 42% After Hours
CDT Environmental Technology shares surged 42% after hours following an SEC filing to sell up to 62 million Class A shares.
Why Is Bakkt Stock Falling Friday?
Why Is Bakkt Stock Falling Friday?
Bakkt, Inc.'s stock down on direct offering news. Dilutive nature of offering and bearish market sentiment cause concern.
Why Is Kratos Stock Falling Friday?
Why Is Kratos Stock Falling Friday?
KTOX falls after $1 billion public offering priced, dilution concerns arise. Underwritten offering of 14.3M shares at $84 per share
Whirlpool Stock Slumps After The Bell: Here's Why
Whirlpool Stock Slumps After The Bell: Here's Why
Whirlpool Corp (NYSE:WHR) shares are trading lower in Monday's after-hours session after the company announced a public offering.
Why Is Candel Therapeutics Stock Falling Friday?
Why Is Candel Therapeutics Stock Falling Friday?
Candel Therapeutics stock down on public offering pricing, intends to use proceeds for cancer therapies and development costs.
JIADE To Raise $3 Million Via New Equity Offering
JIADE To Raise $3 Million Via New Equity Offering
The company announced a pricing of $3 million for the offering, involving the sale of 12,000,000 Class A ordinary shares.
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal
SNSE up on acquisition of Faeth Therapeutics, $200M private placement, and addition of PIKTOR to pipeline targeting cancer.
What's Going On With Neo-Concept International Stock Friday?
What's Going On With Neo-Concept International Stock Friday?
NCI's stock rose after closing a $8.1 million public offering on Feb. 11, 2026, using proceeds for business expansion and working capital.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved